Bristol Myers Squibb (BMY) Net Margin Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Margin Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
1,568.00 |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
-2,848.00 |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
-501.00 |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
-5,859.00 |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
-12.00 |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
931.00 |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
- |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
134.00 |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
| Mar 31, 2026 |
134.00 |
| Dec 31, 2025 |
807.00 |
| Sep 30, 2025 |
823.00 |
| Jun 30, 2025 |
-266.00 |
| Mar 31, 2025 |
12,234.00 |
| Dec 31, 2024 |
-1,426.00 |
| Sep 30, 2024 |
-791.00 |
| Jun 30, 2024 |
-514.00 |
| Mar 31, 2024 |
-12,036.00 |
| Dec 31, 2023 |
-288.00 |
| Sep 30, 2023 |
330.00 |
| Jun 30, 2023 |
648.00 |
| Mar 31, 2023 |
898.00 |
| Dec 31, 2022 |
-204.00 |
| Sep 30, 2022 |
159.00 |
| Jun 30, 2022 |
352.00 |
| Mar 31, 2022 |
-669.00 |
| Dec 31, 2021 |
11,093.00 |
| Sep 30, 2021 |
-439.00 |
| Jun 30, 2021 |
994.00 |
| Mar 31, 2021 |
2,543.00 |
| Dec 31, 2020 |
-7,654.00 |
| Sep 30, 2020 |
-384.00 |
| Jun 30, 2020 |
-2,275.00 |
| Mar 31, 2020 |
-3,501.00 |
| Dec 31, 2019 |
-3,238.00 |
| Sep 30, 2019 |
-1,069.00 |
| Jun 30, 2019 |
1,639.00 |
| Mar 31, 2019 |
68.00 |
| Dec 31, 2018 |
6,247.00 |
| Sep 30, 2018 |
1,787.00 |
| Jun 30, 2018 |
-1,063.00 |
| Mar 31, 2018 |
-193.00 |
| Dec 31, 2017 |
-5,857.00 |
| Sep 30, 2017 |
-747.00 |
| Jun 30, 2017 |
-555.00 |
| Mar 31, 2017 |
484.00 |
| Dec 31, 2016 |
2,196.00 |
| Sep 30, 2016 |
810.00 |
| Jun 30, 2016 |
2,778.00 |
| Mar 31, 2016 |
-242.00 |
| Dec 31, 2015 |
-563.00 |
| Sep 30, 2015 |
-402.00 |
| Jun 30, 2015 |
-1,393.00 |
| Mar 31, 2015 |
309.00 |
| Dec 31, 2014 |
-1,715.00 |
| Sep 30, 2014 |
-13.00 |
| Jun 30, 2014 |
-579.00 |
| Mar 31, 2014 |
782.00 |
| Dec 31, 2013 |
-699.00 |
| Sep 30, 2013 |
3,640.00 |
| Jun 30, 2013 |
-1,158.00 |
| Mar 31, 2013 |
-1,301.00 |
| Dec 31, 2012 |
-251.00 |
| Sep 30, 2012 |
-4,444.00 |
| Jun 30, 2012 |
57.00 |
| Mar 31, 2012 |
94.00 |
| Dec 31, 2011 |
5,005.00 |
| Sep 30, 2011 |
-179.00 |
| Jun 30, 2011 |
467.00 |
| Mar 31, 2011 |
438.00 |
| Dec 31, 2010 |
-16,920.00 |
| Sep 30, 2010 |
2,524.00 |
| Jun 30, 2010 |
62.00 |
| Mar 31, 2010 |
2,288.00 |